Skip to main content

Award-Winning eClinical Platform Powered by AI | Clinion

On this Page

  • What is a Single-Blind Study?
  • When is a Single-Blind Study used in Clinical Trials?
  • How does Clinion support Single-Blind Studies?
  • What it looks like in practice
  • Related Terms
  • Related Articles
  • Category

What is a Single-Blind Study?

A single-blind study is a type of clinical trial in which participants do not know which treatment they have been assigned, while investigators or designated study personnel are aware of the treatment allocation. Blinding participants helps reduce bias that may influence how they perceive or report treatment effects.

When is a Single-Blind Study used in Clinical Trials?

Single-blind studies are used when participant blinding is important to reduce bias, but investigators need to know the assigned treatment to safely administer the intervention or monitor participants. They may be appropriate for certain drug, device, or behavioral studies where full blinding is not practical.

The decision to use a single-blind design depends on the study objectives, intervention, and protocol requirements.

Depending on the study design, unblinding may occur for an individual participant, a specific study site, or the entire trial. Every unblinding event is typically documented and controlled to maintain study integrity and regulatory compliance.

How does Clinion support Single-Blind Studies?

During study setup, study teams can configure single-blind study designs, user roles, treatment allocation rules, and access permissions within Clinion's unified eClinical platform. Role-based controls help ensure that treatment assignments are visible only to authorized study personnel while remaining concealed from participants.

Clinion RTSM also supports participant randomization, treatment assignment, and investigational product dispensing while maintaining the protocol-defined blinding strategy throughout the study.

What it looks like in practice

A clinical trial compares an investigational medication with a placebo to evaluate its effectiveness. Participants are not informed which treatment they receive, helping reduce reporting bias, while designated study personnel know the treatment assignment to manage drug dispensing and participant safety according to the study protocol.

Category

Study Setup & Design